drugset / Trial / NCT00014352
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Anticoagulant drugs such as warfarin may reduce the risk of blood clots. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus warfarin in treating patients who have prostate cancer.
Timeline
- Start
- 2000-09
- Primary completion
- 2003-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |
| Subject | Doxorubicin | Other / unclassified | — | Intravenous |
| Subject | Ketoconazole | Small molecule | — | Oral |
| Subject | Warfarin | Small molecule | — | Oral |
| Subject | estramustine | Other / unclassified | — | Oral |